Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

von Mackensen, S; Kalnins, W; Krucker, J; Weiss, J; Miesbach, W; Albisetti, M; Pabinger, I; Oldenburg, J (2017). Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentrates. Haemophilia, 23(4):566-574.

Sandrock-Lang, K; Oldenburg, J; Wiegering, V; Halimeh, S; Santoso, S; Kurnik, K; Fischer, L; Tsakiris, D A; Sigl-Kraetzig, M; Brand, B; Bührlen, M; Kraetzer, K; Deeg, N; Hund, M; Busse, E; Kahle, A; Zieger, B (2015). Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. Thrombosis and Haemostasis, 113(4):782-791.

Biswas, A; Ivaskevicius, V; Thomas, A; Varvenne, M; Brand, B; Rott, H; Haussels, I; Ruehl, H; Scholz, Ute; Klamroth, R; Oldenburg, J (2014). Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Annals of Hematology, 93(10):1665-1676.

Tiede, A; Huth-Kühne, A; Oldenburg, J; Grossmann, R; Geisen, U; Krause, M; Brand, B; Alberio, L; Klamroth, R; Spannagl, M; Knöbl, P (2009). Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland. Annals of Hematology, 88(4):365-370.

Ulrich, S; Brand, B; Speich, R; Oldenburg, J; Asmis, L (2008). Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland. Swiss Medical Weekly, 138(7-8):100-107.

This list was generated on Wed Apr 25 18:43:32 2018 CEST.